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Human CAG repeat diseases manifest themselves through the common pathology of 
neurodeneration. This pathological link is attributed to the property shared by all nine of 
these diseases: an expanded polyglutamine (polyQ) tract. The most evident result of 
polyQ expansion is protein aggregation, and it is believed that this phenomenon is partly 
responsible for conferring cytotoxic properties on the mutated protein. Apart from 
sequestering the mutated protein, cellular aggregates are able to incorporate native 
proteins via polyQ-mediated aggregation, thus disrupting important cellular pathways. 
Using Drosophila melanogaster as a disease model, researchers have been able to 
compile collections of these so-called disease modifiers for most of the CAG repeat 
diseases. Moreover, a recently characterized Drosophila gene, Dikar, appears to 
synergistically react with polyQ-expanded proteins in an especially strong fashion, 
causing a synthetic lethal phenotype. One potential mechanism by which Dikar causes 
synthetic lethality involves the genetic construct used to achieve ectopic gene expression: 
the Gal4-UAS system in conjunction with the Drosophila eye-specific transcription 
factor Glass and its enhancer sequence GMR. A suspected chromatin remodelling 
complex, Dikar may create a feedback loop involving GMR that would result in 
increased polyQ expression and thus cell death. To test whether this phenomenon was 
responsible for synthetic lethality, a (GFP) reporter gene assay was carried out using two 
versions of GMR: longGMR and shortGMR. The findings of this study demonstrated that 
Dikar did not affect GMR-driven expression levels of the GFP reporter. Therefore, it was 
concluded that synthetic lethality is not the result of a self-perpetuating circuit but rather 
involves either direct or indirect interactions between Dikar and the polyQ protein.  
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Introduction 
CAG repeat expansion mutations are a type of genetic aberration responsible for nine 
human neurodegenerative diseases, including X-linked spinobulbar muscular atrophy, a 
series of cerebellar atrophies, and Huntington’s disease.1 In these diseases, native regions 
of CAG repeats become expanded within the protein-coding regions of affected genes; as 
a result, the mutation is manifested in the protein products as an expanded stretch of 
glutamine residues.2 The mechanism(s) by which native polyglutamine (polyQ) 
sequences become expanded remain unclear. One hypothesis postulates that during the 
processes of DNA replication and/or DNA repair, a phenomenon termed strand slippage 
occurs in the relatively unstable polyQ region of the gene, with the result of increasing 
the number of CAG trinucleotide units.3 While numerous genes possess native polyQ 
sequences, the length of these structures remains stable at ∼30Q; an increase to 35Q will 
become a risk factors for disease while expansions beyond 40Q will almost certainly lead 
to a disease phenotype.4 Moreover, the number of CAG copies is correlated both with the 
severity of the disease as well as the age of onset, with longer polyQ stretches being more 
detrimental.2,4 In terms of inheritance, CAG repeat diseases are autosomal dominant; 
physiologically, the expanded polyglutamine stretch leads to a dual loss-of-function and 
gain-of-function mutation of affected genes.5 
Despite their occurrence among different genes located throughout distinct areas 
of the genome, CAG repeat mutations result in common pathological manifestations. 
Mainly, all polyQ expansion-induced diseases are characterized by a senescence of the 
central nervous system and its associated structures.6 In Huntington’s disease, the 
affected gene is responsible for the production of the huntingtin protein.7 Normal 
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huntingtin is expressed ubiquitously in humans and is present at higher levels in the 
neurons of the CNS, especially in the brain striatum.5 Crucially, neuronal cells exhibit 
increased sensitivity to the polyQ-mutated form of huntingtin (mHtt), with research 
demonstrating that neurons die from cytoplasmic mHtt concentrations that do not 
significantly disrupt the functions of other cell types.8 This phenomenon has also been 
observed in other CAG repeat diseases; consequently, the disease phenotypes are the 
direct result of gradual brain atrophy. The symptoms of CAG repeat-induced 
neurodegeneration, while varied across the individual diseases, include motor function 
impairment, psychological alterations, and cognitive decline, with all nine diseases 
resulting in either symptoms development or even death at approximately the fifth decade 
of life.9 
Due to the phenotypic similarities of CAG repeat diseases, it is clear that the 
expanded polyQ region plays a crucial role in initiating pathological processes. Indeed, 
this novel structure significantly alters the physiological properties of the affected 
protein. Most importantly, the expanded polyQ stretch confers aggregating capabilities on 
the mutated protein, leading to the gain-of-function aspect of the mutation. Depending on 
the size of the expanded polyQ stretch, mutants will exhibit significant β-structure and/or 
protofibril characteristics.10 These structural changes are responsible for aberrant protein 
folding that leads to protein aggregation at the molecular level as well as inclusion, or 
aggresome, formation at the microscopic level. Interestingly, polyQ-mutated proteins do 
not appear to be capable of inducing conformational changes that lead to aggregation of 
wild-type protein.11 Thus, the presence of an expanded polyQ region is necessary for this 
phenomenon to take place.  
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The role of aggregation in disease development is currently a point of debate. Due 
to the phenotypic similarities of CAG repeat diseases to other neurodegenerative diseases 
that exhibit amyloid-like protein inclusions, it has been proposed that the molecular event 
of aggregation is a critical milestone that leads to the development of polyQ-mutated 
protein cytotoxicity.12 Moreover, the fact that the length of the mutated polyQ region is 
related both to enhanced aggregation capabilities as well as the severity of pathology 
suggests that aggregation contributes significantly to disease development. Not only do 
aggregates sequester the mutated protein, leading to the loss-of-function aspect of the 
mutation, but they also are able to recruit other native proteins that contain wild-type 
polyQ stretches.13,14 Thus, aggregation has the potential to disrupt vital cellular pathways.  
Nevertheless, the role of inclusions, or aggresomes, in the disease process has 
been suggested to be beneficial. On the one hand, aggresomes seem to be a final result of 
the molecular phenomenon of aggregation, indicating that cellular mechanisms have 
proven incapable of coping with the accumulation of misfolded protein. On the other 
hand, evidence suggests that aggresomes provide a microenvironment that reduces the 
concentration of the more toxic monomeric form of the polyQ-mutated protein.15 
Moreover, Taylor et al. found aggresomes display significant chaperone, proteasome, and 
autophagy activity, and that they allow for an enhanced turnover of aggregated polyQ-
mutated protein.16 Therefore, aggresomes could enable the cell to more effectively target 
its response pathways.  
The ability of inclusions to enter the nucleus is a hallmark of CAG repeat 
diseases. Yang et al. found that whereas cytoplasmic inclusions localized in the 
perinuclear region enhanced cell survival, inclusions within the nucleus exhibited a high 
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degree of toxicity.17 This group synthesized aggregates of polyQ protein in vitro and 
introduced them into cultured neuronal cell nuclei by engineering a nuclear localization 
signal (NLS) as part of the protein. Their findings suggest the formation of nuclear 
inclusions is an important factor that influences aggregate cytotoxicity despite the 
existence of cytoplasmic inclusions, which had little impact on cell survival. An 
explanation for this dichotomy is that numerous transcription factors possess polyQ 
regions that enable these proteins to be incorporated into nuclear inclusions via polyQ-
mediated aggregation, with potentially detrimental effects on the regulation of gene 
expression.18-20 Thus, understanding the interactions between polyQ-mutated protein 
aggregates and native proteins such as those present in the nucleus is crucial to building a 
more complete model of polyQ-induced pathology.  
To advance this aim, various model systems have been used to investigate the 
genetic dynamics of CAG repeat diseases. In particular, Drosophila melanogaster has 
proven to be well suited for the study of human neurodegenerative diseases. An important 
application of Drosophila melanogaster, as it relates to polyQ-related neurodegeneration, 
has been its use for elucidating genes that interact with polyQ-mutated proteins to alter 
the disease phenotype, so-called disease modifiers. Through the use of genetically 
engineered versions of the Drosophila P-element, various groups have carried out 
genome-wide mutagenesis screens that either up-regulate or down-regulate native 
Drosophila genes in the presence of transgenic polyQ sequences, either the complete 
human disease gene or simply the polyQ region.21-25 
In the case of up-regulation, expression of target genes has often been limited to 
the Drosophila eye. This has been achieved through the use of the eye-specific 
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transcription factor Glass and its enhancer sequence GMR in conjunction with the yeast-
derived Gal4-UAS binary system of ectopic gene expression.26,27 Limiting this genetic 
construct’s expression nearly exclusively in the eyes gives researchers flexibility to inflict 
substantive damage on neuronal tissue that can be easily visualized but that will not 
compromise the life of the organism, since the Drosophila eye is not an essential 
structure for viability.28 However, Glass-driven transcription has been demonstrated to 
take place outside of eye tissues, making it likely that “leaky” expression of those genes 
under the control of Gal4-UAS will occur.29 In over-expressing ectopic polyQ proteins in 
the eyes, researchers produced morphological alterations that resulted in what is 
commonly referred to as a “rough” eye phenotype. Through genetic screens, numerous 
modifiers that alter this rough eye phenotype, either suppressing or enhancing it, have 
been discovered for several of the CAG repeat diseases, and these findings have been 
used to explore possible targets for therapeutic approaches.  
 Until recently, it was believed that genome-wide screens for disease modifiers 
could be carried out simply by combining a human polyQ protein with the up-regulated 
Drosophila targeted gene in the F1 generation and looking for changes in the rough eye 
defect.  Nevertheless, Zhang et al. characterized a Drosophila gene, Dikar, that, when 
over-expressed in combination with several types of polyQ proteins, displayed 
synergistic interaction with polyQ proteins that resulted in synthetic lethality.30 
Additionally, when overexpressed in the absence of polyQ, Dikar itself was able to cause 
a rough eye-like phenotype. However, unlike polyQ proteins, Dikar over-expression at 
high levels did not cause widespread death. These findings suggest that the current 
approach used for the screening of disease modifiers in polyQ-induced neurodegeneration 
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is incapable of detecting the most “reactive” modifiers, since the synthetic lethal 
phenotype they produce will virtually eliminate any chances of recovering those 
genotypes containing them in a usual F1 screen.  
 The mechanism(s) through which Dikar produces synthetic lethality remain 
unclear. One possibility is related to the presumed cellular function of Dikar. Sequence 
analysis has demonstrated Dikar contains an acetyl transferase domain and is the 
homologue of the human CECR2 gene, a chromatin remodeling complex that is known to 
activate a set of downstream genes.31,32 Because Dikar potentially plays a role in the 
regulation of gene expression, its effect on polyQ cytotoxicity may involve a feedback 
loop in which overexpression of Dikar drives expression of the polyQ protein above 
experimentally set levels, overwhelming cellular coping mechanisms and resulting in 
widespread cell death. This self-perpetuating circuit would presumably have its effect 
within the region of GMR, since this sequence is the link between the expression of 
Dikar and polyQ via the Gal4-UAS system (Figure 1). To determine whether this 
phenomenon is responsible for the synthetic lethal phenotype, a reporter gene assay was 
conducted using green fluorescent protein (GFP) as a reporter, both in the absence and 








Materials and Methods 
Culture media and Drosophila stocks: Fruit flies were raised using corn/agar media 
(H2O, agar, cornmeal, baker’s yeast, table sugar, Moldex dissolved in ethanol) and 
incubated at 25°C. The following alleles were obtained from the Bloomington 
Drosophila Stock Center: longGMR-Gal4 (No. 8605), shortGMR-Gal4 (No. 1104), UAS-
2xEGFP (No. 6658). The d10135 chromosome, which carries UAS-linked Dikar, was 
obtained from the Berkeley Drosophila Genome Project.  
 
Fly dissection and fluorescence microscopy: Third instar larvae were dissected in 
phosphate buffer (PBS, 130 mM NaCl, 7 mM Na2HPO4·2H2O, 3 mM NaH2PO4·2H2O, 
pH 7.0) to expose and isolate eye disc structures. Tissues were mounted on slides using 
cover slips and PBS, and they were immediately visualized using an Olympus 
microscope. Green fluorescent images of tissues were taken with a digital camera 
mounted on the microscope (CCD Spot, Diagnostic Instrument, Inc.). Images of 20 
different tissue samples were taken at minimum for each of the four genotypes being 
analyzed.  
 
Image processing and statistical analysis: Digital images taken from fluorescence 
microscopy were processed using the software ImageJ (The National Institutes of 
Health). Images were split by color channels, and only the green channel was used for 
measuring photon intensity. The “region of interest” (ROI) tool of the software was used 
to draw the borders of the areas to be quantified. Areas chosen were those that displayed 
intermediate intensities relative to all the signals detected for a given image. The mean 
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intensity values of the designated areas were quantified by the software within a 0-255 
range. These values were used to construct data sets for each of the four genotypes being 
analyzed. Using the “Analysis ToolPack” add-in of Excel (2011 version), the data sets for 
the control and experimental groups were statistically analyzed using the “t-Test: Two-
Sample Assuming Unequal Variances” setting in order to generate p values. The data set 
for genotype +//+ ; longGMR-Gal4 // + ; UAS-2xEGFP // + ; +//+ (control) was 
compared to that of genotype +//+ ; longGMR-Gal4 // + ; UAS-2xEGFP // UAS-Dikar ; 
+//+ (experimental) and the date set for genotype +//+ ; shortGMR-Gal4 // + ; UAS-
2xEGFP // + ; +//+ (control) was compared to that of genotype +//+ ; shortGMR-Gal4 // 
















Genetic manipulations to produce control genotypes: Two types of genetic crosses were 
carried out to generate four genotypes of interest. The first type involved a cross of the 
following genotypes: (♂) X/Y ; longGMR-Gal4 / longGMR-Gal4 ; +/+ ; +/+  X  (♀) X/X 
; +/+ ; UAS-2xEGFP / UAS-2xEGFP ; +/+. This cross produced an F1 generation all 
containing the following autosomes: longGMR-Gal4 / + ; UAS-2xEGFP  / + ; +/+. 
Consequently, all members of this generation possessed fluorescence in the eye discs. An 
analogous sequence was carried out using males carrying the shortGMR construct instead 
of longGMR. Therefore, this type of genetic cross produced offspring containing both 
GMR-Gal4, either shortGMR or longGMR, and UAS-2xEGFP (control).  
 
Genetic manipulations to produce experimental genotypes: The second type of cross 
involved more complex genetics due to the challenges posed by combining GMR-Gal4, 
UAS-2xEGFP, and UAS-Dikar together in one genotype (Figure 2). Mainly, 
homozygotes for GMR-Gal4 and UAS-Dikar are difficult to establish because this 
genotype is unstable. Therefore, a genotype carrying both of these genetic elements in the 
heterozygous condition (GMR-Gal4 on C-2 and UAS-Dikar on C-3) had to be designed 
with the use of balancer chromosomes in order to suppress any recombination that would 
split the UAS sequence from its downstream target gene. The type of balancer 
chromosome employed was actually a set of two reciprocally translocated balancer 
autosomes, represented as T(2;3)CyO-TM6, and they were established in a male line. 
Due to gene dose imbalance, however, a genotype carrying the translocated 
chromosomes (e.g. + ; + / T(2;3)CyO-TM6) can only produce two types of viable 
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gametes: + ; + and T(2;3)CyO-TM6. Given this limitation, it was expected that only 50% 
of the F1 generation that resulted from a cross of these males with females used in the 
control crosses would live; that is, only those organisms carrying viable gametic 
combinations. Once offspring were generated, there was an additional challenge. Due to 
the genetic design, only 50% of viable offspring would display eye disc fluorescence. 
The other 50% would contain the translocated balancer chromosomes in addition to UAS-
2xEGFP. Normally these two groups would be differentiated easily in the adult form 
since the balancer chromosome contains a dominant marker: CyO. However, because the 
experimental design consisted of analyzing larvae, this phenotypic distinction had not yet 
developed. The means to overcome this limitation was simply to dissect larvae randomly, 
knowing that each larvae chosen possessed a 50% chance of exhibiting eye disc 
fluorescence. As was the case for the control, the type of genetic manipulation described 
above was carried out using the longGMR-Gal4 construct in one instance and the 
shortGMR-Gal4 construct in the other.  
   
shortGMR: 20 images of tissue samples were analyzed for genotype +//+ ; shortGMR-
Gal4 // + ; UAS-2xEGFP // + ; +//+ (Figure 4). Photon intensity data from these images 
were used to calculate a mean photon intensity value of green fluorescence for this 
genotype, designated “sGMR” (Table 1). This data set displayed the following 
parameters: mean = 59.706, variance = 221.108. Also, 20 images of tissue samples were 
analyzed for genotype +//+ ; shortGMR-Gal4 // + ; UAS-2xEGFP // UAS-Dikar ; +//+ 
(Figure 4). Mean photon intensity values for these images were used to calculate a mean 
photon intensity value of green fluorescence for this genotype, designated “sGMR 
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Dikar” (Table 1). This data set displayed the following parameters: mean = 63.541, 
variance = 152.360. Both data sets were compared, and they generated a p value of 0.168. 
This indicates there is no statistically significant difference between the two data sets (p < 
0.05). 
 
longGMR: 22 images of different tissue samples were analyzed for genotype +//+ ; 
longGMR-Gal4 // + ; UAS-2xEGFP // + ; +//+ (Figure 4). Mean photon intensity values 
for these images were used to calculate a mean photon intensity value of green 
fluorescence for this genotype, designated “lGMR” (Table 1). This data set displayed the 
following parameters: mean = 7.194, variance = 6.228. Also, 23 images of different 
tissue samples were analyzed for genotype +//+ ; longGMR-Gal4 // + ; UAS-2xEGFP // 
UAS-Dikar ; +//+ (Figure 4). Mean photon intensity values for these images were used to 
calculate a mean photon intensity value of green fluorescence for this genotype, 
designated “lGMR Dikar” (Table 1). This data set displayed the following parameters: 
mean = 7.020, variance = 6.494. Both data sets (lGMR & lGMR Dikar) were compared, 
and they generated a p value of 0.409. This indicates there is no statistically significant 
difference between the two data sets (p < 0.05).  
 
longGMR vs. shortGMR: Mean photon intensity values between longGMR and 
shortGMR-driven expression of GFP reporter were compared (Figure 3). Since genotypes 
either containing Dikar or not were not found to be statistically different, their data sets 
were combined for the purposes of this comparison. The mean intensity value for 
longGMR-driven expression was 12.79 while that for shortGMR-driven expression was 
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123.25, indicating that shortGMR-driven expression is ~9 times greater than longGMR-
























The purpose of this investigation was to determine if a feedback expression loop, 
involving the enhancer sequence GMR and the Drosophila protein Dikar, was the cause 
of the synthetic lethality that results from the simultaneous ectopic overexpression of 
human polyQ-mutated proteins and Dikar. Because the phenomenon of synthetic lethality 
at present is limited to Dikar expression, a self-perpetuating circuit is a potential 
explanation for this supposed isolated observation. Indeed, expression of polyQ proteins 
at certain levels is sufficient to cause widespread cell death, with a feedback loop 
resulting in an exact scenario.  
 The genetic construct used to study CAG repeat diseases in Drosophila utilizes 
various genetic elements (Figure 1). A Drosophila eye-predominant transcription factor, 
Glass, along with its enhancer sequence GMR, is used to virtually limit ectopic 
expression to the eyes. Moreover, the yeast-derived Gal4-UAS system is used to drive 
expression of target genes. These two elements are linked via the GMR-Gal4 construct, 
which ultimately combines Glass-induced transcription to the expression of genes 
downstream of UAS sequences.  Within this genetic construct, a potential weakness 
involves the ability of target genes to modulate the dynamics of either Glass or the GMR 
sequence, thereby altering the experimentally pre-determined expression levels of the 
target genes. In considering Dikar and its cellular role in the regulation of gene 
expression via chromatin remodelling, synthetic lethality can be the result of Dikar-
induced changes on the GMR sequence, which would lead to increased expression of 
Gal4 and thus of the polyQ-containing protein.  
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A reporter gene assay using green fluorescent protein (GFP) was carried out to 
determine Dikar’s effect on GMR-driven expression of target genes. The experimental 
design consisted of the following elements. First, two common GMR derivatives were 
used: longGMR (lGMR) and shortGMR (sGMR). The primary differences between these 
two are: 1) longGMR carries more Glass-binding sites than shortGMR and 2) shortGMR 
achieves greater levels of expression in the eyes than does longGMR. Two versions of 
GMR were used to further validate the experimental findings inasmuch as both GMR 
sequences yield the same results. Second, 2 types of genotypes were generated for each 
GMR sequence (4 genotypes of interest in total). One type contained the GMR-Gal4 and 
UAS-2xEGFP constructs only and served as a control to establish baseline expression of 
the GMR sequence. The other genotype contained the GMR-Gal4 and UAS-2xEGFP 
constructs as well as UAS-Dikar (Figure 2), and it served to determine Dikar’s effect, if 
any, on the expression of GMR-controlled genetic elements.  
GFP reporter expression was measured using fluorescence microscopy. In order 
to optimize visualization of the green fluorescence signal, eye tissue samples were 
obtained from third instar larvae. In particular, eye discs, primordial structures of the 
adult eye, were dissected out and prepared for microscopy. This made for a more efficient 
means of obtaining appropriate tissues without the need to process tough, adult cuticle. 
Simultaneous to visualization, tissue samples were imaged using a CCD camera to reduce 
“background” signals. No qualitative difference was observed between those genotypes 
possessing the same GMR sequence either in the absence or presence of Dikar (Figure 4). 
Subsequently, images were processed, and this data was used to generate quantitative 
mean photon intensity values for each of the four genotypes of interest (Table 1). 
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Statistical analysis of these values demonstrated no significant difference between 
genotypes possessing the same GMR sequence either in the absence or presence of Dikar. 
Moreover, the difference in reporter expression observed between the longGMR and 
shortGMR constructs (Figure 3) reflected the dynamics of these two sequences found in 
the literature. This outcome validated both the genetic design as well as the experimental 
findings.  Given this data, it was concluded that Dikar did not affect GMR-driven 
expression of the GFP reporter.  
Therefore, the experimental results did not support the concept of a Dikar 
expression feedback loop as the causation of polyQ-related synthetic lethality in 
Drosophila. These findings have two major implications. First, a discrediting of the 
expression feedback loop hypothesis posits a more complex relation between polyQ-
mutated proteins and Dikar. Based on the experimental results, it is likely that synthetic 
lethality is the product of either direct or indirect interactions between these two gene 
products. As such, further research on the mechanism(s) by which Dikar causes synthetic 
lethality is needed. Second, the probability that Dikar is the only gene capable of eliciting 
a “legitimate” synthetic lethal phenotype seems unlikely. Given this assumption, the 
current approach to finding polyQ disease modifiers in Drosophila via genome-wide 
screens appears to have a major flaw. Simply stated, these screens are unable to recover 
the most powerful modifiers: those that modify polyQ cytotoxicity to the point of death. 
Thus, a re-evaluation of this protocol that reflects this reality is necessary for the 
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Parameters sGMR sGMR Dikar   lGMR lGMR Dikar 
Mean 59.706 63.541   7.195 7.020 
Variance 221.108 152.360   6.228 6.494 
Observations 20.000 20.000   22.000 23.000 
Pearson Correlation 0.199 -   6.364 - 
Hypothesized Mean Difference 0.000 -   0.000 - 
df 19.000 -   43.000 - 
t Stat -0.989 -   0.232 - 
P(T<=t) one-tail 0.168 -   0.409 - 
t Critical one-tail 1.729 -   1.681 - 
P(T<=t) two-tail 0.335 -   0.818 - 
t Critical two-tail 2.093 -   2.017 - 
 
Table 1. Average photon intensity values & statistical analysis data. Mean value 
comparison between data sets of genotypes sGMR (59.706) and sGMR Dikar (63.541) 
determined no statistically significant difference between the two (p value = 0.168). 
Similarly, the comparison between data sets of genotypes lGMR (7.195) and lGMR Dikar 
(7.020) determined no statistically significance difference between the two (p value = 
0.409). Therefore, expression of Dikar does not impact expression of GMR-driven 





















Figure 1. Hypothetical Dikar expression feedback loop. A) Eye-predominant 
transcription factor Glass binds to its enhancer sequence, GMR, and drives transcription 
of Gal4 gene. B) Gal4 binds its enhancer sequence, UAS, and activates transcription of 
downstream genes; in this genetic construct these are the Drosophila gene Dikar and a 
human polyQ-containing transgene. C) Dikar is able to affect GMR-driven transcription, 
perhaps through chromatin remodelling, and causes expression of the Gal4 gene above 
experimentally-set levels. D) An increased dose of Gal4 drives increased expression of 
the polyQ-disease protein, which acts as a cytotoxin and whose level of expression 
overwhelms cellular coping mechanisms. This self-perpetuating feedback circuit is one 
supposed mechanism by which Dikar expression, in combination with polyQ expression, 







Figure 2. Genetic design to generate experimental genotypes. Top) Males carrying the 
translocated balancer chromosome T(2;3) CyO-TM6 (represented as “T(2;3) a” & “T(2;3) 
b”) only produced two sets of viable gametes. Bottom) Cross to generate experimental 
genotypes (lGMR Dikar and sGMR Dikar) produced two distinct autosomal genotypes 
in the F1 generation. Out of these, only the one carrying the GMR-Gal4 construct 




Figure 3. longGMR vs. shortGMR-driven expression of GFP reporter. Experimental 
findings presented in Table 1 demonstrated no difference between GMR-driven 
expression of GFP reporter either in the presence or absence of Dikar expression (p > 
0.05). Therefore, both genetic constructs for each GMR type, long and short, were used 
for the purpose of comparing levels of expression between longGMR and shortGMR. 









































Figure 4. Representative fluorescence microscopy images of larval eye disc structures. 
A-D) Eye discs dissected from “sGMR” genotype. E-H) Eye discs dissected from 
“sGMR Dikar” genotype. There is no obvious difference in mean photon intensity 
between images A-D and images E-H, indicating no qualitative impact of Dikar 
expression on sGMR-driven expression of GFP reporter. I-L) Eye discs dissected from 
“lGMR” genotype. M-P) Corresponding digitally enhanced versions of I-L for the 
purpose of visualizing eye disc structures present in image. Q-T) Eye discs dissected 
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from “lGMR Dikar” genotype. U-X) Corresponding digitally enhanced versions of 
images Q-T for the purpose of visualizing eye disc structures present in image. 
Analogous to sGMR, there is no obvious difference in mean photon intensity between 
images I-L and images Q-T, indicating no qualitative impact of Dikar expression on 
lGMR-driven expression of GFP reporter. 
 
 
 
 
 
 
 
 
  
